Find a specific notice:
Notice Type
Departmental
Notice Title

Revocation of Consent to the Distribution of Medicines

Publication Date
14 May 2015

Tags

Medicines Act Revocation of consent to the distribution of medicines Health

Notice Number

2015-go2799

Page Number

2862

Issue Number

53
Title
View PDF
File Type and Size
PDF (21 KB)

Pursuant to section 35(1)(b) of the Medicines Act 1981, the Minister of Health hereby revokes consent to the distribution in New Zealand of the following medicines:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Venlafaxine XR
Venlafaxine hydrochloride 84.869mg equivalent to Venlafaxine 75mg
Modified release capsule
PSM Healthcare Limited trading as API Consumer Brands
Wockhardt Limited, Maharashtra State, India

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Venlafaxine XR
Venlafaxine hydrochloride 169.738mg equivalent to Venlafaxine 150mg
Modified release capsule
PSM Healthcare Limited trading as API Consumer Brands
Wockhardt Limited, Maharashtra State, India

Dated this 8th day of May 2015.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).